Peter T Ivanovich

  • 3701 Citations
1964 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

1956Internship, Saint Mary's Hospital
1962Residency, Saint Mary's Hospital

Education/Academic qualification

MD, Saint Louis University

… → 1955

Fingerprint Dive into the research topics where Peter T Ivanovich is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 15 Similar Profiles
Renal Dialysis Medicine & Life Sciences
Dialysis Medicine & Life Sciences
Artificial Kidneys Medicine & Life Sciences
Chronic Renal Insufficiency Medicine & Life Sciences
Membranes Medicine & Life Sciences
Anemia Medicine & Life Sciences
Type 2 Diabetes Mellitus Medicine & Life Sciences
Chronic Kidney Failure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1964 2019

7 Citations (Scopus)
Open Access
Symporters
Stroke Volume
Heart Failure
Morbidity
Mortality
2 Citations (Scopus)

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Charytan, D. M., Solomon, S. D., Ivanovich, P. T., Remuzzi, G., Cooper, M. E., McGill, J. B., Parving, H. H., Parfrey, P., Singh, A. K., Burdmann, E. A., Levey, A. S., Eckardt, K. U., McMurray, J. J. V., Weinrauch, L. A., Liu, J., Claggett, B., Lewis, E. F. & Pfeffer, M. A., May 1 2019, In : Diabetes, Obesity and Metabolism. 21, 5, p. 1199-1208 10 p.

Research output: Contribution to journalArticle

Metformin
Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Chronic Kidney Failure
Kidney Diseases
1 Citation (Scopus)

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Mc Causland, F. R., Claggett, B., Burdmann, E. A., Chertow, G. M., Cooper, M. E., Eckardt, K. U., Ivanovich, P. T., Levey, A. S., Lewis, E. F., McGill, J. B., McMurray, J. J. V., Parfrey, P., Parving, H. H., Remuzzi, G., Singh, A. K., Solomon, S. D., Toto, R. D. & Pfeffer, M. A., Mar 1 2019, In : American Journal of Kidney Diseases. 73, 3, p. 309-315 7 p.

Research output: Contribution to journalArticle

Anemia
Dialysis
Heart Failure
Therapeutics
Placebos
1 Citation (Scopus)

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD

Charytan, D. M., Solomon, S. D., Ivanovich, P. T., Remuzzi, G., Cooper, M. E., McGill, J. B., Parving, H. H., Parfrey, P., Singh, A. K., Burdmann, E. A., Levey, A. S., de Zeeuw, D., Eckardt, K. U., McMurray, J. J. V., Claggett, B., Lewis, E. F. & Pfeffer, M. A., Oct 1 2017, In : American Journal of Kidney Diseases. 70, 4, p. 522-531 10 p.

Research output: Contribution to journalArticle

Chronic Kidney Failure
Heart Failure
Stroke
Myocardial Infarction
Glomerular Filtration Rate
8 Citations (Scopus)

Coronary artery disease is a predictor of progression to dialysis in patients with chronic kidney disease, type 2 diabetes mellitus, and anemia: An analysis of the trial to reduce cardiovascular events with aranesp therapy (TREAT)

Sabe, M. A., Claggett, B., Burdmann, E. A., Desai, A. S., Ivanovich, P. T., Kewalramani, R., Lewis, E. F., McMurray, J. J. V., Olson, K. A., Parfrey, P., Solomon, S. D. & Pfeffer, M. A., Jan 1 2016, In : Journal of the American Heart Association. 5, 4, e002850.

Research output: Contribution to journalArticle

Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Anemia
Coronary Artery Disease
Dialysis